OP Asset Management Ltd purchased a new position in shares of Chemed Corporation (NYSE:CHE – Free Report) in the 1st quarter, Holdings Channel reports. The fund purchased 15,925 shares of the company’s stock, valued at approximately $6,016,000.
Other large investors have also modified their holdings of the company. Monetary Solutions Ltd bought a new position in Chemed in the 4th quarter worth about $25,000. Los Angeles Capital Management LLC bought a new position in Chemed in the 4th quarter worth approximately $26,000. BOK Financial Private Wealth Inc. acquired a new stake in Chemed in the 4th quarter valued at approximately $27,000. Global Retirement Partners LLC raised its stake in Chemed by 200.0% during the 4th quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after acquiring an additional 58 shares in the last quarter. Finally, Rothschild Investment LLC boosted its position in Chemed by 800.0% during the 4th quarter. Rothschild Investment LLC now owns 108 shares of the company’s stock worth $46,000 after acquiring an additional 96 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.
Chemed Stock Performance
Shares of NYSE CHE opened at $453.10 on Friday. Chemed Corporation has a 1 year low of $365.20 and a 1 year high of $562.77. The firm has a market cap of $6.01 billion, a P/E ratio of 24.69, a PEG ratio of 1.68 and a beta of 0.54. The stock has a fifty day moving average price of $424.73 and a two-hundred day moving average price of $424.70. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85.
Chemed Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 16th. Shareholders of record on Thursday, May 28th were given a $0.60 dividend. The ex-dividend date was Thursday, May 28th. This represents a $2.40 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is 13.08%.
Analyst Ratings Changes
A number of research analysts have recently commented on the company. Weiss Ratings raised Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, April 29th. Royal Bank Of Canada increased their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research report on Monday, April 27th. Oppenheimer lowered their target price on shares of Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research note on Friday, February 27th. Wall Street Zen downgraded shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Monday, April 27th. Two research analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $501.50.
Check Out Our Latest Report on Chemed
Insider Transactions at Chemed
In other news, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction that occurred on Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the transaction, the chief executive officer owned 90,219 shares of the company’s stock, valued at $37,993,927.47. The trade was a 2.17% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Andrea R. Lindell sold 1,347 shares of the business’s stock in a transaction that occurred on Tuesday, June 9th. The stock was sold at an average price of $447.33, for a total transaction of $602,553.51. Following the completion of the sale, the director owned 4,578 shares in the company, valued at $2,047,876.74. The trade was a 22.73% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 3.33% of the stock is currently owned by corporate insiders.
Chemed Profile
Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.
The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.
See Also
- Five stocks we like better than Chemed
- MDA Space Targets US Defense Market With $620M Acquisition
- Carnival’s Second Quarter: Is the Stock Still Complicated?
- Domino’s Stock Slides to 52-Week Low as Investors Digest CEO Change
- Microsoft Solves AI’s Biggest Bottleneck With Chevron Deal
Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHE – Free Report).
Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.
